Bvf Inc Olema Pharmaceuticals, Inc. Transaction History
Bvf Inc
- $1.85 Billion
- Q3 2025
A detailed history of Bvf Inc transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Bvf Inc holds 5,295,893 shares of OLMA stock, worth $46 Million. This represents 2.76% of its overall portfolio holdings.
Number of Shares
5,295,893
Previous 5,295,893
-0.0%
Holding current value
$46 Million
Previous $22.6 Million
126.53%
% of portfolio
2.76%
Previous 0.89%
Shares
6 transactions
Others Institutions Holding OLMA
# of Institutions
134Shares Held
65.9MCall Options Held
379KPut Options Held
13K-
Bain Capital Life Sciences Investors, LLC Boston, MA6.84MShares$59.5 Million21.2% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY6.79MShares$59 Million2.11% of portfolio
-
Black Rock Inc. New York, NY4MShares$34.8 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X03.59MShares$31.2 Million0.02% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.47MShares$30.2 Million1.06% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $351M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...